A treatment study for Mild Cognitive Impairment (MCI)
The Memory Improvement Through Nicotine Dosing (MIND) study will determine whether daily transdermal nicotine will have a positive effect on early memory loss in people diagnosed with MCI.
We need your help.
If you are a healthy, non-smoking adult age 55+ and are interested in learning more about this study, please call us at (800) NEW-STUDY. There is no cost to participate.
To learn more about this Study, call our office at (800) NEW-STUDY or visit our website at www.Syrentis.com
Click on the following link to see if you qualify
https://apex.clinicalconductor.com/CCEWeb/Forms/frmUserHome.aspx?Mode=1
